Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress - Cytokinetics (NASDAQ:CYTK)

SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European

Related Keywords

Portugal ,United Kingdom ,Lisbon ,Lisboa ,Scotland ,Martin Maron ,Perry Elliott ,Gregory Lewis ,Mary Ellen Jay ,Diane Weiser ,Youtube ,University Of Glasgow ,European Society Of Cardiology ,Harvard Medical School ,Institute For Cardiovascular Science ,Linkedin ,Corporate Affairs ,Pestana Palace Lisboa Hotel ,Cytokinetics Incorporated ,Exchange Commission ,Facebook ,Scotland Inherited Cardiac Conditions Service ,University College London ,Cardiopulmonary Exercise Testing Laboratory ,School Of Cardiovascular ,Metabolic Health ,International Congress ,Hypertrophic Cardiomyopathy Center ,European Summer Time ,Quantitative Understanding ,Obstruction Impact ,Late Breaking Clinical Trial ,Heart Failure ,European Society ,Lahey Hospital ,Medical Center ,Principal Investigator ,Mary Ellen Jay Chair ,Section Head ,Heart Failure Medical Director ,Harvard Medical ,Lead Clinician ,Honorary Senior Lecturer ,Cardiovascular Medicine ,Cardiovascular Science ,University College ,Private Securities Litigation Reform Act ,Safe Harbor ,Vice President ,